Ebola Vaccine Doses Headed to Congo Amid Fast-Spreading Outbreak
The WHO and partners will ship 70,000 doses of the Ervebo Ebola vaccine to Congo, though it is licensed for the Zaire virus, not the Bundibugyo virus behind the current outbreak. Early lab and animal data suggest it may offer some protection, and 20,000 doses will support a phase III trial. The outbreak has killed 2,476 of 5,208 confirmed cases, with a case fatality rate of 47.5%.
Related stories
Ebola Outbreak in Congo Accelerates Toward Record Death Toll · Infectious disease
Congo's Ebola Outbreak Surpasses Previous Records as Death Toll Climbs · Infectious disease
Spyre halts RA program for anti-TL1A candidate after Phase 2 disappointment · Drug development
This summary is AI-generated and original to Mobble; the linked article is the authoritative source.
Original headline: “Congo to Receive 70,000 Doses of FDA-Approved Ebola Vaccine.” Browse more stories.